BFEC
IONS icon

Benjamin F. Edwards & Company’s Ionis Pharmaceuticals IONS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-119
Closed -$4K – 1867
2022
Q2 		$4K Hold
119
– – ﹤0.01% 1584
2022
Q1 		$4K Hold
119
– – ﹤0.01% 1565
2021
Q4 		$4K Buy
119
+55
+86% +$1.73K ﹤0.01% 1553
2021
Q3 		$2K Buy
64
+8
+14% +$301 ﹤0.01% 1629
2021
Q2 		$2K Sell
56
-2,033
-97% -$79.6K ﹤0.01% 1622
2021
Q1 		$94K Hold
2,089
– – 0.01% 854
2020
Q4 		$118K Hold
2,089
– – 0.01% 761
2020
Q3 		$99K Sell
2,089
-44
-2% -$2.44K 0.01% 741
2020
Q2 		$126K Buy
2,133
+44
+2% +$2.45K 0.01% 677
2020
Q1 		$99K Hold
2,089
– – 0.01% 691
2019
Q4 		$126K Hold
2,089
– – 0.01% 725
2019
Q3 		$125K Buy
+2,089
New +$136K 0.01% 683
2018
Q3 		– Sell
-41
Closed -$2K – 1627
2018
Q2 		$2K Hold
41
– – ﹤0.01% 1521
2018
Q1 		$2K Sell
41
-83
-67% -$4.22K ﹤0.01% 1519
2017
Q4 		$6K Sell
124
-36
-23% -$1.97K ﹤0.01% 1310
2017
Q3 		$8K Buy
160
+22
+16% +$1.15K ﹤0.01% 1225
2017
Q2 		$7K Buy
138
+55
+66% +$2.56K ﹤0.01% 1180
2017
Q1 		$3K Hold
83
– – ﹤0.01% 1227
2016
Q4 		$4K Hold
83
– – ﹤0.01% 1095
2016
Q3 		$3K Sell
83
-577
-87% -$18.1K ﹤0.01% 1012
2016
Q2 		$15K Sell
660
-707
-52% -$22.8K ﹤0.01% 718
2016
Q1 		$55K Hold
1,367
– – 0.01% 485
2015
Q4 		$85K Hold
1,367
– – 0.02% 433
2015
Q3 		$55K Sell
1,367
-40
-3% -$2.07K 0.01% 504
2015
Q2 		$81K Buy
1,407
+270
+24% +$17.2K 0.02% 499
2015
Q1 		$72K Buy
+1,137
New +$77.1K 0.02% 499

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Benjamin F. Edwards & Company's IONS Position: Q3 2022 in Review

Benjamin F. Edwards & Company sold out of Ionis Pharmaceuticals (IONS) in Q3 2022, closing a stake of 119 shares — an estimated $4K sold.

Benjamin F. Edwards & Company first reported a position in IONS in Q1 2015 and held it in 26 quarters. The position peaked at $126K in Q2 2020. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • Benjamin F. Edwards & Company reported no remaining Ionis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 119 Ionis Pharmaceuticals shares in Q3 2022, an estimated $4K.
  • Benjamin F. Edwards & Company first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 26 quarters.
  • Benjamin F. Edwards & Company's Ionis Pharmaceuticals position peaked at $126K in Q2 2020.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2022, filed 28 Oct 2022.